Umbralisib
Back to search| Scientific Name: | Umbralisib |
| Brand Name: | UKONIQ |
| Company Owner: | Not Available |
| Mechanism Of Action | The PI3K pathway is a deregulated in malignancies, leading to the overexpression of p110 isoforms (p110α, p110β, p110δ, p110γ) that induces malignant transformation in cells. |
| Description of the Drug: | Umbralisib is a kinase inhibitor used to treat rare forms of refractory lymphoma. |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB14989
